Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
Omar Mhaimeed, Zain Burney, Stacey L. Schott, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100649-100649
Open Access | Times Cited: 20

Showing 20 citing articles:

Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study
Wongsakorn Luangphiphat, Pinidphon Prombutara, Praewpannarai Jamjuree, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317202-e0317202
Open Access
Role of Statins in Reducing Cardiovascular Mortality: A Systematic Review of Long-Term Outcomes
Bhavna Seth, David Okello, Sobia Zaheer Ullah, et al.
Cureus (2025)
Open Access
Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus
Sulagna Mukherjee, Seung‐Soon Im
Biomedicines (2025) Vol. 13, Iss. 2, pp. 359-359
Open Access
Refining the impact of early intermittent hyperlipidemia on atherosclerosis: Unveiling the role of neutrophil reprogramming, sex differences, gut microbiota, and maternal hypercholesterolemia
Héctor A. Cabrera-Fuentes, William A. Boisvert
The FASEB Journal (2025) Vol. 39, Iss. 5
Closed Access
Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor
Mart Reimund, Altaira D. Dearborn, Giorgio Maria Paolo Graziano, et al.
Nature (2024)
Closed Access | Times Cited: 3
No Standard Risk Factors Is the Marker for Clinical Outcomes in Patients With Myocardial Infarction
Kenichi Sakakura
JACC Asia (2024) Vol. 4, Iss. 7, pp. 517-518
Open Access | Times Cited: 2
Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study
Ville Kytö, Aleksi Tornio
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100702-100702
Open Access | Times Cited: 2
Comparing the cardiovascular risk-reducing effects of polyunsaturated fatty acids in fish oil and krill oil: A network meta-analysis
Thi-Phuong-Thao Pham, Thi-Van Hoang, Thi-Thuy-Duong Le, et al.
Journal of Functional Foods (2024) Vol. 120, pp. 106379-106379
Open Access | Times Cited: 2
Addition of Bempedoic Acid to Statin-Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk. A Single Centre Prospective Study
Giuseppe Marazzi, Giuseppe Caminiti, Marco Alfonso Perrone, et al.
(2024)
Open Access | Times Cited: 1
Reduced circulating CD63+ extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans
Brachyahu Meir Kestecher, Krisztína Németh, S. Ghosal, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Comparison between the Friedewald, Martin and Sampson Equations and LDL-C Quantification by Ultracentrifugation in a Mexican Population
Giovanny Fuentevilla-Álvarez, Marí­a Elena Soto, José Antonio García Valdivia, et al.
Diagnostics (2024) Vol. 14, Iss. 12, pp. 1241-1241
Open Access
Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study
Giuseppe Marazzi, Giuseppe Caminiti, Marco Alfonso Perrone, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 9, pp. 286-286
Open Access
Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study
Rony M. Zeenny, Rachel Abdo, Chadia Haddad, et al.
Pharmacy (2024) Vol. 12, Iss. 6, pp. 171-171
Open Access
PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
Maram H. Abduljabbar
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1581-1581
Open Access
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk Score
Subhash Banerjee, Rick Weideman, David Jacob, et al.
JACC Advances (2024) Vol. 4, Iss. 1, pp. 101459-101459
Open Access
Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records
Giulia Barbati, Caterina Gregorio, Arjuna Scagnetto, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309470-e0309470
Open Access
Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions
Xue Liu, Weijiao Wang, Qiang Li, et al.
International Journal of Smart and Nano Materials (2024) Vol. 15, Iss. 3, pp. 610-651
Open Access
Sex differences in LDL‐C reduction response to evolocumab: A propensity score matching analysis
Yun He, Yuqing Wei, Huang Guang-ming, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 11, pp. 861-869
Closed Access
Page 1

Scroll to top